Literature DB >> 1457273

Duchenne muscular dystrophy.

J R Gorospe1, E P Hoffman.   

Abstract

Advances in the understanding of the genetic basis for Duchenne muscular dystrophy over the past 4 years has led to the quick application of molecular diagnostics. More recently, attention has turned towards acquiring a better understanding of dystrophin biochemistry and the pathophysiologic consequences of dystrophin deficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457273

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  5 in total

1.  Social deprivation in Duchenne muscular dystrophy: population based study.

Authors:  K Bushby; S Raybould; S O'Donnell; J G Steele
Journal:  BMJ       Date:  2001-11-03

Review 2.  Pharmacologic and genetic therapy for childhood muscular dystrophies.

Authors:  D M Escolar; C G Scacheri
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 5.081

3.  Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle.

Authors:  M J Cullen; J Walsh; L V Nicholson
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Mechanics of dystrophin deficient skeletal muscles in very young mice and effects of age.

Authors:  Michael A Lopez; Sherina Bontiff; Mary Adeyeye; Aziz I Shaibani; Matthew S Alexander; Shari Wynd; Aladin M Boriek
Journal:  Am J Physiol Cell Physiol       Date:  2021-05-12       Impact factor: 5.282

5.  Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.

Authors:  Y W Chen; P Zhao; R Borup; E P Hoffman
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.